Status:
COMPLETED
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Coronary Stenting
Eligibility:
All Genders
40-67 years
Phase:
NA
Brief Summary
The investigators prospectively studied the effect of aspirin on platelet function in 106 stable outpatients 6 months after successful percutaneous coronary angioplasty. Participants were randomized i...
Detailed Description
Background: Acetylsalicylic acid (aspirin) is widely used in the secondary prevention of coronary artery disease. There is controversy regarding the prevalence of aspirin resistance in patients with ...
Eligibility Criteria
Inclusion
- 6 months post stent without complication
Exclusion
- subacute stent thrombosis
- unable to discontinue plavix
- dont accept to participate
- contraindication for ASA use
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00966485
Start Date
October 1 2006
End Date
October 1 2008
Last Update
August 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Namazi hospital
Shiraz, Fars, Iran, 55318